Ophelia is the industry leader in virtual care for opioid use disorder
Get your free white paper
Key highlights
7.6 million individuals with OUD are not receiving treatment
Total healthcare costs among patients with OUD up to 9-times greater than costs among patients without OUD
High-quality telehealth platforms like Ophelia are able to expand the impacts of MAT on patient health and cost by increasing access and improving retention
Bundling MAT services to further improve retention and reduce costs
Contributors
Zack Gray
Zack started Ophelia after losing someone he loved to an opioid overdose.
He’s a Y Combinator-backed entrepreneur, Columbia University-funded research scholar, and a Wharton MBA graduation speaker. Previously, Zack led customer acquisition for a residential solar startup, which he helped grow to $30M in revenue. He studied astrophysics and philosophy at Columbia University and received his MBA from The Wharton School.
Dr. Arthur Robin Williams
Dr. Arthur Robin Williams is a codesigner of Ophelia and brings a wealth of knowledge on substance use disorders. Currently, he is an academic addiction psychiatrist, and a Research Scientist at New York State Psychiatric Institute supported with NIH, SAMHSA, and CDC funding. He has served as an expert speaker or consultant to the NIH HEAL Initiative, the National Quality Forum, and the American Psychiatric Association to aide quality measure development efforts for the opioid crisis under the OUD Cascade of Care framework.
Dr. Adam Bisaga
Dr. Adam Bisaga codesigned Ophelia alongside Dr. Arthur Williams in order to help patients struggling with opioid addiction. He is an academic addiction psychiatrist and NIH funded researcher developing novel approaches to treat substance use disorders. Dr. Bisaga is a member of the UN Office of Drugs and Crime Expert Panel and has worked with UN agencies internationally training providers and developing treatment guidances.
Get your free white paper
